R1, a company that specializes in healthcare revenue cycle management, has announced its intention to acquire Humata Health, which focuses on utilizing artificial intelligence to streamline the prior authorization process. This move is aimed at enhancing efficiency in preapproval requirements that insurers impose for various medical treatments, thereby furthering R1's mission to automate payment processes for healthcare providers.
The acquisition is anticipated to be finalized in the third quarter of this year. Following the transaction, Humata’s team will work on integrating its innovative technology into R1’s existing revenue cycle platform, although specifics regarding the financial aspects of the deal were not disclosed by an R1 representative.
R1 is optimistic that this acquisition will bolster its AI capabilities, assisting healthcare providers in reducing administrative burdens and improving their financial outcomes. Operating out of Utah, R1 processes over 600 million transactions annually through a network of approximately 1,000 providers, utilizing a billing system designed to eliminate the necessity for multiple software applications.
In contrast to R1's diverse approach to claims processing, Humata Health, founded in 2023 by a physician trained at the Mayo Clinic, is dedicated solely to prior authorizations. Humata offers an AI-driven solution that recognizes insurer policies, generates prior authorization requests, and tracks them to final approval, boasting an impressive first-pass approval rate of up to 96%.
R1 CEO Joe Flanagan commented on the acquisition, stating, "Humata significantly enhances our coverage of the authorization process." The prior authorization system has long been a contentious issue within the healthcare sector, with patients expressing that the preapprovals create challenges, and providers pointing out the additional administrative tasks they entail, all while insurers argue that these authorizations are crucial for controlling costs and healthcare spending.
R1 envisions a future where real-time prior authorizations are commonplace, a vision echoed by recent federal regulations set to take effect in 2024 that will require insurers to expedite prior authorization decisions and use technology to facilitate electronic preapprovals. Additionally, during the previous summer, the Trump administration garnered commitments from insurers to ensure that at least 80% of electronic prior authorization requests receive real-time responses by next year.
Meanwhile, other technology firms are also launching solutions aimed at improving real-time prior authorizations. For instance, Epic, a leading electronic health record provider, recently introduced a tool that allows clinicians to quickly verify insurance prior authorization requirements.
